About

It all started with a groundbreaking discovery at the University of Virginia. Researchers identified a critical biomarker—phosphatidylserine (PS)—on sperm that is essential for fertilization. This breakthrough revealed a key missing piece in male fertility testing: identifying sperm that are truly capable of fertilizing an egg.

This discovery led to the creation of PS Fertility, a company dedicated to improving fertility care outcomes by revolutionizing the diagnosis and treatment of male infertility. With innovative technology that goes beyond traditional semen analysis, PS Fertility helps physicians and patients better assess male infertility and provides clear answers to couples. By improving diagnostic precision, we exist to save couples time and money while bringing them closer to their dream of starting a family.